Drug
Lanthanum carbonate clinical trials
Also written Fosrenol.
A product of Lanthanum; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
39 studies that test it; most in 2009 (6)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 21 · Other 18
Shire (13) · Bayer (6) · University of Illinois at Chicago (2) · Universitair Ziekenhuis Brussel (1) · Northwestern University (1) · Endeavor Health (1) · VA Office of Research and Development (1) · The Cleveland Clinic (1)
Often tested with
Tested in the same studies.
Sevelamer (3) · Niacinamide (2) · Calcitriol (1) · Roxadustat (1) · Calcium acetate (1) · Calcium Carbonate (1)
Studies
Open first, then newest update. How each study uses lanthanum carbonate is read from its arms, and is right about nine times in ten.
Testing it · 39
- Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and NephrolithiasisCompletedPhase 3Universitair Ziekenhuis BrusselNCT03346369Written as Lanthanum Carbonate
- Healthy Combine StudyCompletedPhase 1Northwestern UniversityNCT03136705Written as Lanthanum Carbonate
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney DiseaseCompletedNot applicableEndeavor HealthNCT01002872Written as Lanthanum Carbonate (Fosrenol)
- Phosphate Lowering in CKD TrialCompletedPhase 4VA Office of Research and DevelopmentNCT02209636Written as Lanthanum carbonate
- The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidECompletedPhase 2The Cleveland ClinicNCT02258074Written as Lanthanum Carbonate
- To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate PowderStatus unknownPhase 1/2Grand Life Science (Liaoning) Co., Ltd.NCT04440696Written as Lanthanum Carbonate 500 MG
- Different Effects of Non-calcium Phosphate Binders on Serum CalciumCompletedPhase 4Medical University of LodzNCT03451019Written as Lanthanum Carbonate
- Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCompletedPhase 3ShireNCT00151918Written as Lanthanum carbonate
- Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal DiseaseCompletedPhase 4ShireNCT00160121Written as Lanthanum carbonate
- A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.CompletedPhase 3ShireNCT00150540Written as Lanthanum carbonate
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCompletedPhase 1ShireNCT00925704Written as Lanthanum carbonate + Calcitriol
- Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCompletedPhase 1ShireNCT00875017Written as Lanthanum Carbonate
- Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy AdultsCompletedPhase 1ShireNCT00880750Written as Lanthanum carbonate Chewable Tablets (Fosrenol)
- Head to Head Study Against Sevelamer HydrochlorideCompletedPhase 3ShireNCT00441545Written as Fosrenol (Lanthanum Carbonate)
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCompletedPhase 2ShireNCT01696279Written as Lanthanum Carbonate
- Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKDCompletedPhase 2ShireNCT01128179Written as Lanthanum carbonate
- Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCompletedPhase 3ShireNCT00151931Written as Lanthanum carbonate
- Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their BloodCompletedPhase 3ShireNCT00150566Written as Lanthanum carbonate
- Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney DiseaseCompletedPhase 2ShireNCT00234702Written as Lanthanum carbonate
- Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TerminatedPhase 4ShireNCT00452478Written as Lanthanum carbonate
See all 39 studies that test lanthanum carbonate →
Given in every arm · 1 — lanthanum carbonate is usual care beside what is tested
As the comparator · 1 — what is tested is compared with lanthanum carbonate
Codes
What other systems call lanthanum carbonate · ClinicalTrials.gg INT004157
- MeSH (NLM) C119467lanthanum carbonateOne source NLM
- UNII (FDA) 490D9F069TLANTHANUM CARBONATEConfirmed FDA, NLM
- RxNorm 234416One source FDA
- NCI Thesaurus C61801Lanthanum CarbonateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C119467 | lanthanum carbonate | One source NLM |
| UNII (FDA) | 490D9F069T | LANTHANUM CARBONATE | Confirmed FDA, NLM |
| RxNorm | 234416 | — | One source FDA |
| NCI Thesaurus | C61801 | Lanthanum Carbonate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.